生命科学资讯

Lab-grown models of human brains are advancing rapidly. Can ethics keep pace?

CRISPR/Cas9 Knock-In Tagging: Simplifying the Study of Endogenous Biology

Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma

OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits

Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech

10x Genomics (Nasdaq: TXG) Xenium Powers ASTRA Atlas of 2,000 Asia-Pacific Tumor Samples - Stock Titan

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium - PR Newswire

Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. - PR Newswire

Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga

Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - Seeking Alpha

New experimental drug could transform care for cancer patients - The Independent

Roche Shares Rise After Breast-Cancer Pill Shows Positive Results in Trial - The Wall Street Journal

Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st

Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena

Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters

Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina

Amylin could reign supreme in the next wave of obesity drugs

High-resolution climate model forecasts a wet, turbulent future

Roche Gives Glimpse of Cancer Genomics Potential of New Axelios Sequencer - GenomeWeb